{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:28:35Z","timestamp":1780676915718,"version":"3.54.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.113057","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T19:34:31Z","timestamp":1651865671000},"page":"113057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Beneficial effects of carvedilol modulating potassium channels on the control of glucose"],"prefix":"10.1016","volume":"150","author":[{"given":"Xian-Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2022.113057_bib1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM200008243430813","article-title":"Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus","volume":"343","author":"Bell","year":"2000","journal-title":"New Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2022.113057_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/2040622313494986","article-title":"Strategies for preventing type 2 diabetes: an update for clinicians","volume":"4","author":"Khavandi","year":"2013","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"3","key":"10.1016\/j.biopha.2022.113057_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"New Engl. J. Med."},{"issue":"9311","key":"10.1016\/j.biopha.2022.113057_bib4","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2022.113057_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/08037059209065120","article-title":"The metabolic and circulatory response to beta-blockade in hypertensive men is correlated to muscle capillary density","volume":"1","author":"Lithell","year":"1992","journal-title":"Blood Press."},{"issue":"18","key":"10.1016\/j.biopha.2022.113057_bib6","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.biopha.2022.113057_bib7","first-page":"1900","article-title":"The effect of carvedilol on blood glucose levels in normal albino rats","volume":"7","author":"Suresha","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"issue":"11","key":"10.1016\/j.biopha.2022.113057_bib8","first-page":"1277","article-title":"Pharmacologic management of hypertension in patients with diabetes","volume":"78","author":"Whalen","year":"2008","journal-title":"Am. Fam. Physician"},{"issue":"2","key":"10.1016\/j.biopha.2022.113057_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCOUTCOMES.112.965046","article-title":"Glucose, blood pressure, and cardiovascular risk","volume":"5","author":"Lleva","year":"2012","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4239\/wjd.v5.i4.536","article-title":"Novel treatment approaches in hypertensive type 2 diabetic patients","volume":"5","author":"Castro Torres","year":"2014","journal-title":"World J. Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2022.113057_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00210-003-0858-5","article-title":"Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell","volume":"369","author":"Vieira","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113057_bib12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/01.HYP.22.6.922","article-title":"Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells","volume":"22","author":"Yue","year":"1993","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.biopha.2022.113057_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/157016112799959323","article-title":"The effects of newer beta-adrenoceptor antagonists on vascular function in cardiovascular disease","volume":"10","author":"Wehland","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113057_bib14","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1440-1681.2010.05427.x","article-title":"Effects of carvedilol on delayed rectifier and transient inactivating potassium currents in rat hippocampal CA1 neurons","volume":"37","author":"Duan","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2022.113057_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejphar.2018.07.025","article-title":"Characterization and molecular basis for the block of Kv1.3 channels induced by carvedilol in HEK293 cells","volume":"834","author":"Yang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113057_bib16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjp.0706508","article-title":"Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy","volume":"147","author":"Kawakami","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113057_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00008.2017","article-title":"Pancreatic \u03b2-cell electrical activity and insulin secretion: of mice and men","volume":"98","author":"Rorsman","year":"2018","journal-title":"Physiol. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2022.113057_bib18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrendo.2013.166","article-title":"K(ATP) channels and islet hormone secretion: new insights and controversies","volume":"9","author":"Ashcroft","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","article-title":"Sulfonylureas and their use in clinical practice","volume":"11","author":"Sola","year":"2015","journal-title":"Arch. Med. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2022.113057_bib20","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.2337\/db16-1170","article-title":"Kv2.1 clustering contributes to insulin exocytosis and rescues human \u03b2-cell dysfunction","volume":"66","author":"Fu","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.113057_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2019.05.006","article-title":"Carvedilol blockage of delayed rectifier Kv2.1 channels and its molecular basis","volume":"855","author":"Cheng","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113057_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4331\/wjbc.v5.i2.85","article-title":"Oxidation of KCNB1 K(+) channels in central nervous system and beyond","volume":"5","author":"Sesti","year":"2014","journal-title":"World J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2022.113057_bib23","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1523\/JNEUROSCI.19-05-01728.1999","article-title":"Identification of the Kv2.1 K+ channel as a major component of the delayed rectifier K+ current in rat hippocampal neurons","volume":"19","author":"Murakoshi","year":"1999","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2022.113057_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/hh2301.100349","article-title":"Genetic manipulation of cardiac K(+) channel function in mice: what have we learned, and where do we go from here?","volume":"89","author":"Nerbonne","year":"2001","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.biopha.2022.113057_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cmet.2007.07.010","article-title":"Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion","volume":"6","author":"Jacobson","year":"2007","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.biopha.2022.113057_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.112.199083","article-title":"The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets","volume":"344","author":"Li","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2022.113057_bib27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/mol.52.5.821","article-title":"Phosphorylation of the Kv2.1 K+ channel alters voltage-dependent activation","volume":"52","author":"Murakoshi","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113057_bib28","first-page":"709","article-title":"Pharmacokinetics of carvedilol in older and younger patients","volume":"4","author":"Morgan","year":"1990","journal-title":"J. Hum. Hypertens."},{"issue":"11","key":"10.1016\/j.biopha.2022.113057_bib29","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00005344-198710111-00015","article-title":"Pharmacokinetics and disposition of carvedilol in humans","volume":"10","author":"Neugebauer","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113057_bib30","first-page":"S27","article-title":"Clinical pharmacology of carvedilol","volume":"70","author":"Tomlinson","year":"1992","journal-title":"Clin. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2022.113057_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0005-2736(96)00097-1","article-title":"Carvedilol-liposome interaction: evidence for strong association with the hydrophobic region of the lipid bilayers","volume":"1284","author":"Cheng","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.biopha.2022.113057_bib32","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nrd2983","article-title":"Voltage-gated potassium channels as therapeutic targets","volume":"8","author":"Wulff","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib33","first-page":"281","article-title":"Mammalian osteoclasts express a transient potassium channel with properties of Kv1.3","volume":"2","author":"Arkett","year":"1994","journal-title":"Recept Channels"},{"issue":"10","key":"10.1016\/j.biopha.2022.113057_bib34","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.celrep.2016.08.016","article-title":"Decrease of a current mediated by Kv1.3 channels causes striatal cholinergic interneuron hyperexcitability in experimental parkinsonism","volume":"16","author":"Tubert","year":"2016","journal-title":"Cell Rep."},{"issue":"21","key":"10.1016\/j.biopha.2022.113057_bib35","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1007\/s00018-018-2851-7","article-title":"Caveolar targeting links Kv1.3 with the insulin-dependent adipocyte physiology","volume":"75","author":"P\u00e9rez-Verdaguer","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113057_bib36","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1210\/jc.2005-0725","article-title":"A new variant in the human Kv1.3 gene is associated with low insulin sensitivity and impaired glucose tolerance","volume":"91","author":"Tschritter","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib37","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.1403024","article-title":"Antigenic stimulation of Kv1.3-deficient th cells gives rise to a population of foxp3-independent T cells with suppressive properties","volume":"195","author":"Grishkan","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.113057_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bcp.2019.03.016","article-title":"Fighting rheumatoid arthritis: Kv1.3 as a therapeutic target","volume":"165","author":"Serrano-Albarr\u00e1s","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113057_bib39","doi-asserted-by":"crossref","first-page":"C345","DOI":"10.1152\/ajpcell.00091.2005","article-title":"Voltage-gated potassium channel Kv1.3 regulates GLUT4 trafficking to the plasma membrane via a Ca2+-dependent mechanism","volume":"290","author":"Li","year":"2006","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113057_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/14728222.9.3.571","article-title":"Kv1.3 potassium channel blockade as an approach to insulin resistance","volume":"9","author":"Desir","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"issue":"8","key":"10.1016\/j.biopha.2022.113057_bib41","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00125-003-1159-8","article-title":"Voltage-dependent K(+) channels in pancreatic beta cells: role, regulation and potential as therapeutic targets","volume":"46","author":"MacDonald","year":"2003","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.biopha.2022.113057_bib42","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.2337\/db17-1223","article-title":"Whole-organism chemical screening identifies modulators of pancreatic \u03b2-cell function","volume":"67","author":"Matsuda","year":"2018","journal-title":"Diabetes"},{"issue":"6315","key":"10.1016\/j.biopha.2022.113057_bib43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/350232a0","article-title":"Determination of the subunit stoichiometry of a voltage-activated potassium channel","volume":"350","author":"MacKinnon","year":"1991","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2022.113057_bib44","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1210\/mend.15.8.0685","article-title":"Members of the Kv1 and Kv2 voltage-dependent K(+) channel families regulate insulin secretion","volume":"15","author":"MacDonald","year":"2001","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113057_bib45","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1471-4159.1999.0730849.x","article-title":"Subunit composition of Kv1 channels in human CNS","volume":"73","author":"Coleman","year":"1999","journal-title":"J. Neurochem."},{"issue":"49","key":"10.1016\/j.biopha.2022.113057_bib46","doi-asserted-by":"crossref","first-page":"37675","DOI":"10.1074\/jbc.M605617200","article-title":"Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages","volume":"281","author":"Vicente","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bcp.2011.11.019","article-title":"Carvedilol blocks the cloned cardiac Kv1.5 channels in a beta-adrenergic receptor-independent manner","volume":"83","author":"Jeong","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113057_bib48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1006\/jmcc.2000.1317","article-title":"I(Kr): the hERG channel","volume":"33","author":"Tseng","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113057_bib49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0165-6147(00)01662-X","article-title":"HERG K+ channels: friend and foe","volume":"22","author":"Vandenberg","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"issue":"18","key":"10.1016\/j.biopha.2022.113057_bib50","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.116.024279","article-title":"Patients with long-QT syndrome caused by impaired hERG-encoded K(v)11.1 potassium channel have exaggerated endocrine pancreatic and incretin function associated with reactive hypoglycemia","volume":"135","author":"Hylt\u00e9n-Cavallius","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2022.113057_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(01)00116-4","article-title":"KCNQ potassium channels: physiology, pathophysiology, and pharmacology","volume":"90","author":"Robbins","year":"2001","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2022.113057_bib52","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2337\/db08-1589","article-title":"Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion","volume":"58","author":"M\u00fcssig","year":"2009","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2022.113057_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032148","article-title":"Common variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clamp","volume":"7","author":"van Vliet-Ostaptchouk","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib54","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2337\/db13-1454","article-title":"KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia","volume":"63","author":"Torekov","year":"2014","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2022.113057_bib55","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00424-005-1479-2","article-title":"Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells","volume":"451","author":"Ullrich","year":"2005","journal-title":"Pflugers Arch."},{"issue":"10","key":"10.1016\/j.biopha.2022.113057_bib56","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/jce.12178","article-title":"Differential effects of the \u03b2-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels","volume":"24","author":"Bodi","year":"2013","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113057_bib57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(99)00368-4","article-title":"Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ current in rabbit ventricular myocytes","volume":"376","author":"Cheng","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib58","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/cvr\/cvq398","article-title":"Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications","volume":"89","author":"Ravens","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2022.113057_bib59","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.614","article-title":"Stimulation of glucose uptake in murine soleus muscle and adipocytes by 5-(4-phenoxybutoxy)psoralen (PAP-1) may be mediated by Kv1.5 rather than Kv1.3","volume":"2","author":"Ngala","year":"2014","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.biopha.2022.113057_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s004240000508","article-title":"The expression and regulation of depolarization-activated K+ channels in the insulin-secreting cell line INS-1","volume":"442","author":"Su","year":"2001","journal-title":"Pflugers Arch."},{"issue":"7","key":"10.1016\/j.biopha.2022.113057_bib61","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.lfs.2006.10.012","article-title":"Effects of carvedilol on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes","volume":"80","author":"Deng","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.113057_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fphys.2013.00283","article-title":"The voltage-dependent K(+) channels Kv1.3 and Kv1.5 in human cancer","volume":"4","author":"Comes","year":"2013","journal-title":"Front. Physiol."},{"issue":"19","key":"10.1016\/j.biopha.2022.113057_bib63","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1046\/j.1432-1327.2000.01670.x","article-title":"G-protein mediated gating of inward-rectifier K+ channels","volume":"267","author":"Mark","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib64","doi-asserted-by":"crossref","first-page":"C821","DOI":"10.1152\/ajpcell.1995.269.4.C821","article-title":"G protein regulation of cardiac muscarinic potassium channel","volume":"269","author":"Kurachi","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113057_bib65","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1152\/physrev.1990.70.2.513","article-title":"Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system","volume":"70","author":"Nicoll","year":"1990","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2022.113057_bib66","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jmb.2019.08.014","article-title":"Ion channels of the islets in type 2 diabetes","volume":"432","author":"Jacobson","year":"2020","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113057_bib67","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00424-008-0479-4","article-title":"Adrenaline-induced hyperpolarization of mouse pancreatic islet cells is mediated by G protein-gated inwardly rectifying potassium (GIRK) channels","volume":"456","author":"Iwanir","year":"2008","journal-title":"Pflugers Arch."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2022.113057_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2005.10.059","article-title":"Carvedilol blocks cardiac KATP and KG but not IK1 channels by acting at the bundle-crossing regions","volume":"529","author":"Kikuta","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113057_bib69","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bbrc.2015.02.099","article-title":"Inwardly rectifying Kir2.1 currents in human \u03b2-cells control electrical activity: characterisation and mathematical modelling","volume":"459","author":"Riz","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.113057_bib70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2011.05.067","article-title":"Carvedilol inhibits Kir2.3 channels by interference with PIP(2)-channel interaction","volume":"668","author":"Ferrer","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.biopha.2022.113057_bib71","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2174\/1381612054021015","article-title":"ATP-sensitive potassium channels","volume":"11","author":"Rodrigo","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.biopha.2022.113057_bib72","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1152\/ajpcell.1998.274.1.C25","article-title":"ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells","volume":"274","author":"Yokoshiki","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2022.113057_bib73","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.embor.7400003","article-title":"Potassium channel regulation","volume":"4","author":"Campbell","year":"2003","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.biopha.2022.113057_bib74","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3565(24)36997-6","article-title":"The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells","volume":"283","author":"Yokoshiki","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2022.113057_bib75","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cardiores.2006.05.011","article-title":"Attenuated cardioprotection by ischemic preconditioning in coronary stenosed heart and its restoration by carvedilol","volume":"71","author":"Watanabe","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.biopha.2022.113057_bib76","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2008.07.013","article-title":"Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact","volume":"29","author":"Bayliss","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113057_bib77","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1152\/physrev.00029.2009","article-title":"Molecular background of leak K+ currents: two-pore domain potassium channels","volume":"90","author":"Enyedi","year":"2010","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2022.113057_bib78","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1210\/en.2013-2051","article-title":"Pancreatic \u03b2-cell-specific ablation of TASK-1 channels augments glucose-stimulated calcium entry and insulin secretion, improving glucose tolerance","volume":"155","author":"Dadi","year":"2014","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2022.113057_bib79","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s41598-018-19600-x","article-title":"Cytokine-mediated changes in K(+) channel activity promotes an adaptive Ca(2+) response that sustains \u03b2-cell insulin secretion during inflammation","volume":"8","author":"Dickerson","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2022.113057_bib80","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.1621192114","article-title":"Genetic regulatory signatures underlying islet gene expression and type 2 diabetes","volume":"114","author":"Varshney","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"14","key":"10.1016\/j.biopha.2022.113057_bib81","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1073\/pnas.1201132109","article-title":"TWIK1, a unique background channel with variable ion selectivity","volume":"109","author":"Chatelain","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175069","article-title":"Osteopontin activates the diabetes-associated potassium channel TALK-1 in pancreatic \u03b2-cells","volume":"12","author":"Dickerson","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2022.113057_bib83","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1476-5381.2011.01319.x","article-title":"Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels","volume":"163","author":"Staudacher","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.biopha.2022.113057_bib84","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1111\/bph.12596","article-title":"Modulation of K2P 2.1 and K2P 10.1 K(+) channel sensitivity to carvedilol by alternative mRNA translation initiation","volume":"171","author":"Kisselbach","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib85","doi-asserted-by":"crossref","first-page":"C583","DOI":"10.1152\/ajpcell.00363.2015","article-title":"The potassium channels TASK2 and TREK1 regulate functional differentiation of murine skeletal muscle cells","volume":"311","author":"Afzali","year":"2016","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113057_bib86","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.mehy.2004.08.034","article-title":"PKC-mediated modulation of L-type calcium channels may contribute to fat-induced insulin resistance","volume":"66","author":"McCarty","year":"2006","journal-title":"Med. Hypotheses"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:32:56Z","timestamp":1780486376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222004462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":86,"alternative-id":["S0753332222004462"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113057","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of carvedilol modulating potassium channels on the control of glucose","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113057"}}